{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:15:18Z","timestamp":1770138918171,"version":"3.49.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess the frequency and characteristics of severe relapse in patients with GCA in a real-life setting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In a monocentric database of 530 patients, we retrospectively analysed patients who experienced at least one relapse and distinguished severe from non-severe relapses. Severe relapse was defined by the occurrence of an ischaemic event (ophthalmologic, neurologic, digestive, limb ischaemia), the occurrence of an aortic complication (i.e. new or worsening of aortic dilation, aortic dissection), or new or worsening vascular stenosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>From the cohort of 530 patients, 242 (45.7%) patients experienced relapse at least once, including 13 (2.5% of the cohort) who experienced severe relapse. Among the 464 recorded relapses, 14 (3% of all relapses) were severe. Severe relapse corresponded to the following vascular events: a peripheral limb ischaemia in six patients, a visual event in three patients (including two acute anterior ischaemic anterior neuropathies), an aortic complication in three patients, a mesenteric ischaemia in one patient and an ischaemic stroke in one patient. When compared with the 229 patients who experienced non-severe relapses, severe relapse patients were younger at diagnosis (P\u2009=\u20090.02), and showed more frequently limb claudication at baseline (P\u2009&amp;lt;\u20090.0001) and fewer GCA-related cranial signs (P\u2009&amp;lt;\u20090.0001). At diagnosis, more large-vessel vasculitis on imaging (82% vs 36%, P\u2009=\u20090.002) were observed in patients with severe relapse. The death rate did not differ between patients with severe and non-severe relapses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In a real-life setting, relapse affects nearly half of GCA patients, but severe relapse is rare.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae174","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T22:10:11Z","timestamp":1710799811000},"page":"1386-1391","source":"Crossref","is-referenced-by-count":3,"title":["Frequency and characteristics of severe relapses in giant cell arteritis"],"prefix":"10.1093","volume":"64","author":[{"given":"Nicolas","family":"Lozachmeur","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Caen University Hospital , Caen,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1105-7662","authenticated-orcid":false,"given":"Anael","family":"Dumont","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Caen University Hospital , Caen,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Deshayes","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Caen University Hospital , Caen,","place":["France"]},{"name":"Caen University-Normandie , Caen,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Boutemy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Caen University Hospital , Caen,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gw\u00e9nola","family":"Maign\u00e9","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Caen University Hospital , Caen,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Martin Silva","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Caen University Hospital , Caen,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Caen University Hospital , Caen,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Gallou","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Caen University Hospital , Caen,","place":["France"]},{"name":"Caen University-Normandie , Caen,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9mi","family":"Philip","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Caen University Hospital , Caen,","place":["France"]},{"name":"Caen University-Normandie , Caen,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achille","family":"Aouba","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Caen University Hospital , Caen,","place":["France"]},{"name":"Caen University-Normandie , Caen,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9083-8365","authenticated-orcid":false,"given":"Hubert","family":"de Boysson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Caen University Hospital , Caen,","place":["France"]},{"name":"Caen University-Normandie , Caen,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"2025030500182042800_keae174-B1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"key":"2025030500182042800_keae174-B2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.revmed.2017.03.007","article-title":"Epidemiology and natural history of giant cell arteritis","volume":"38","author":"Mahr","year":"2017","journal-title":"Rev Med Interne"},{"key":"2025030500182042800_keae174-B3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/art.23577","article-title":"Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan","volume":"59","author":"Agard","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2025030500182042800_keae174-B4","doi-asserted-by":"crossref","first-page":"e3851","DOI":"10.1097\/MD.0000000000003851","article-title":"18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: a multicenter cohort of 130 patients","volume":"95","author":"De Boysson","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025030500182042800_keae174-B5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/rheumatology\/keu329","article-title":"Large-vessel giant cell arteritis: a cohort study","volume":"54","author":"Muratore","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2025030500182042800_keae174-B6","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2011-200865","article-title":"Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography","volume":"71","author":"Prieto-Gonz\u00e1lez","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2025030500182042800_keae174-B7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/acr.23901","article-title":"Prevalence of giant cell arteritis relapse in patients treated with glucocorticoids: a meta-analysis","volume":"72","author":"Mainbourg","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025030500182042800_keae174-B8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MD.0b013e31821c4fad","article-title":"Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from Northwestern Spain","volume":"90","author":"Martinez-Lado","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"2025030500182042800_keae174-B9","doi-asserted-by":"crossref","first-page":"1759720x211009029","DOI":"10.1177\/1759720X211009029","article-title":"Large-vessel involvement is predictive of multiple relapses in giant cell arteritis","volume":"13","author":"De Mornac","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2025030500182042800_keae174-B10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MD.0000000000000033","article-title":"Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients","volume":"93","author":"Alba","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"2025030500182042800_keae174-B11","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/jcm11041034","article-title":"Impact of glucocorticoid cumulative doses in a real-life cohort of patients affected by giant cell arteritis","volume":"11","author":"Castan","year":"2022","journal-title":"J Clin Med"},{"key":"2025030500182042800_keae174-B12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40744-018-0112-8","article-title":"Risk associated with cumulative oral glucocorticoid use in patients with giant cell arteritis in real-world databases from the USA and UK","volume":"5","author":"Gale","year":"2018","journal-title":"Rheumatol Ther"},{"key":"2025030500182042800_keae174-B13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2025030500182042800_keae174-B14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"key":"2025030500182042800_keae174-B15","doi-asserted-by":"crossref","first-page":"e736-42","DOI":"10.1016\/S2665-9913(23)00265-5","article-title":"Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept study","volume":"5","author":"Unizony","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"2025030500182042800_keae174-B16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025030500182042800_keae174-B17","doi-asserted-by":"crossref","first-page":"102930","DOI":"10.1016\/j.autrev.2021.102930","article-title":"Epidemiology of major relapse in giant cell arteritis: a study-level meta-analysis","volume":"21","author":"Aussedat","year":"2022","journal-title":"Autoimmun Rev"},{"key":"2025030500182042800_keae174-B18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3899\/jrheum.181127","article-title":"Factors associated with relapse and dependence on glucocorticoids in giant cell arteritis","volume":"47","author":"Dumont","year":"2020","journal-title":"J Rheumatol"},{"key":"2025030500182042800_keae174-B19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.semarthrit.2019.09.008","article-title":"Characteristics and outcomes of patients with ophthalmologic involvement in giant-cell arteritis: a case-control study","volume":"50","author":"Dumont","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2025030500182042800_keae174-B20","doi-asserted-by":"crossref","first-page":"152192","DOI":"10.1016\/j.semarthrit.2023.152192","article-title":"Efficacy and tolerance of methotrexate in a real-life monocentric cohort of patients with giant cell arteritis","volume":"60","author":"Lavergne","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"2025030500182042800_keae174-B21","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1093\/rheumatology\/keab222","article-title":"Real-life analysis of the causes of death in patients consecutively followed for giant cell arteritis in a French centre of expertise","volume":"60","author":"Antonini","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025030500182042800_keae174-B22","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","article-title":"2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC)","volume":"35","author":"Erbel","year":"2014","journal-title":"Eur Heart J"},{"key":"2025030500182042800_keae174-B23","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3899\/jrheum.141347","article-title":"Disease relapses among patients with giant cell arteritis: a prospective, longitudinal cohort study","volume":"42","author":"Kermani","year":"2015","journal-title":"J Rheumatol"},{"issue":"Suppl 103","key":"2025030500182042800_keae174-B24","first-page":"88","article-title":"Risk factors for severe cranial ischaemic events in patients with giant cell arteritis","volume":"35","author":"Grossman","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2025030500182042800_keae174-B25","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1093\/rheumatology\/keaa058","article-title":"Risk factors for severe cranial ischaemic complications in giant cell arteritis","volume":"59","author":"Ho\u010devar","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025030500182042800_keae174-B26","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.7326\/M23-0679","article-title":"Association between vascular 18F-fluorodeoxyglucose uptake at diagnosis and change in aortic dimensions in giant cell arteritis: a cohort study","volume":"176","author":"Moreel","year":"2023","journal-title":"Ann Intern Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae174\/57193003\/keae174.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1386\/57193003\/keae174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1386\/57193003\/keae174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:20:27Z","timestamp":1741134027000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/3\/1386\/7631289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,18]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae174","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,3,18]]}}}